KIROMIC – US Trademark 97484081 of Kiromic Biopharma, Inc.

Trademark image

KIROMIC (U.S. Trademark Serial Number 97484081) is a United States trademark of Kiromic Biopharma, Inc.. The goods and services include: The mark consists of the word KIROMIC and the letter O of the word represents a sun. Pharmaceutical, biologic, and biopharmaceutical preparations; Biopharmaceutical preparations, cell therapies, and gene therapies for preventing, managing, and treating diseases and disorders in oncology, immunology, and immuno-oncology; Biopharmaceutical preparations in the nature of T-cell allogenic therapies; Biological compounds in the nature of human cells used for enhanced delivery of therapeutic agents to targeted cells within the human body; Biological components, namely engineered and edited human cells, being a component in therapeutic preparations for use in diseases and disorders of oncology, immunology, and immune-oncology; Therapeutic preparations for enhancing the targeting, delivery, and effectiveness of cancer treatments; Therapeutic agents for destroying tumor cells and inhibiting tumor growth; Human cells for medical and therapeutic use; T-cells for medical and therapeutic use . The correspondent is KAREN WON of MINTZ, LEVIN, COHN, FERRIS, GLOVSKY, AND.

This trademark was filed on June 30, 2022 as United States Trademark Application Serial Number 97484081. This trademark application is still pending and does not yet have a registration number.

Trademark PTO Status History

July 04, 2022 – NEW APPLICATION ENTERED IN TRAM

View full trademark status information at USPTO

Ownership History

Kiromic Biopharma, Inc.

View documents on file at USPTO

File a Trademark or Get Help With Trademark Law

Select IP monitors top trademarks which have been allowed and granted worldwide. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.

Leave a Reply

Your email address will not be published. Required fields are marked *